Information
-
Trademark
-
99208503
-
International Classifications
-
Filing Date
May 29, 2025
5 months ago
-
Transaction Date
July 12, 2025
3 months ago
-
Status Date
May 29, 2025
5 months ago
-
Location Date
June 27, 2025
4 months ago
-
Status Code
630
-
-
Attorney Docket Number
S2058.20010US00
Attorney Name
Douglas R. Wolf
-
Owners
Mark Drawing Code
3
Mark Identification
ISEMBYLD
Case File Statements
- DM0000: The mark consists of ISEMBYLD in green letters with a black wedge cap above the M.
- GS0051: Monoclonal antibodies for medical purposes; pharmaceutical preparations, namely, antibodies for the treatment of spinal muscular atrophy (SMA); therapeutic preparations comprising apitegromab, being a monoclonal antibody for the treatment of spinal muscular atrophy (SMA), musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders; therapeutic agents and pharmaceutical preparations for the treatment of musculoskeletal disorders, neuromuscular diseases and disorders, genetic diseases and disorders, and neurological diseases and disorders
- CC0000: The color(s) green and black is/are claimed as a feature of the mark.
- GS0441: patient and caregiver support services and medical information relating to spinal muscular atrophy (SMA), apitegromab preparations, case management, financial assistance, copay support, reimbursement support, drug access, patient and caregiver education, and support for infusions and infusion logistics
- GS0421: research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products
Case File Event Statements
-
5/29/2025 - 5 months ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
5/29/2025 - 5 months ago
2 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
7/11/2025 - 3 months ago
4 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
7/11/2025 - 3 months ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
